Caroline Germa
Chief Tech/Sci/R&D Officer at TRANSCENTA HOLDING LIMITED
Profile
Caroline Germa is currently the CMO & Executive VP-Global Medicine Development at Transcenta Holding Ltd.
and the Chief Medical Officer at Ikena Oncology, Inc. She previously worked as the Vice President & Head-Early Development Clinical at AstraZeneca PLC.
Dr. Germa holds a doctorate degree from Universite Paris Cite and undergraduate and graduate degrees from Université De Lille.
Caroline Germa active positions
| Companies | Position | Start |
|---|---|---|
| TRANSCENTA HOLDING LIMITED | Chief Tech/Sci/R&D Officer | 2022-08-07 |
| IKENA ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | 2024-02-28 |
Former positions of Caroline Germa
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2022-08-06 |
Training of Caroline Germa
| Universite Paris Cite | Doctorate Degree |
| Université De Lille | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| IKENA ONCOLOGY, INC. | Health Technology |
| TRANSCENTA HOLDING LIMITED | Health Technology |
- Stock Market
- Insiders
- Caroline Germa
